| Matching cell lines with cancer type and subtype of origin via mutational, epigenomic, and transcriptomic patterns M Salvadores, F Fuster-Tormo, F Supek Science Advances 6 (27), eaba1862, 2020 | 64 | 2020 |
| Mutational signatures are markers of drug sensitivity of cancer cells J Levatić, M Salvadores, F Fuster-Tormo, F Supek Nature Communications 13 (1), 2926, 2022 | 60 | 2022 |
| Passenger mutations accurately classify human tumors M Salvadores, D Mas-Ponte, F Supek PLoS computational biology 15 (4), e1006953, 2019 | 54 | 2019 |
| Loss of the abasic site sensor HMCES is synthetic lethal with the activity of the APOBEC3A cytosine deaminase in cancer cells J Biayna, I Garcia-Cao, MM Álvarez, M Salvadores, J Espinosa-Carrasco, ... PLoS biology 19 (3), e3001176, 2021 | 31 | 2021 |
| The effect of ultrasound on the alkali extraction of proteins from eggshell membranes I Marcet, M Salvadores, M Rendueles, M Díaz Journal of the science of food and agriculture 98 (5), 1765-1772, 2018 | 17 | 2018 |
| Cell cycle gene alterations associate with a redistribution of mutation risk across chromosomal domains in human cancers M Salvadores, F Supek Nature Cancer 5 (2), 330-346, 2024 | 10 | 2024 |
| Prevalence, causes and impact of TP53-loss phenocopying events in human tumors B Fito-Lopez, M Salvadores, MM Alvarez, F Supek BMC biology 21 (1), 92, 2023 | 8 | 2023 |
| Prevalence, causes and impact of TP53-loss phenocopying events in human tumors B Fito-Lopez, M Salvadores, MM Alvarez, F Supek EUROPEAN JOURNAL OF HUMAN GENETICS 32, 57-57, 2024 | | 2024 |
| Multi-Omics Analysis Reveals the Attenuation of the Interferon Pathway as a Driver of Chemo-Refractory Ovarian Cancer D Afenteva, R Yu, A Rajavuori, M Salvadores, IM Launonen, K Lavikka, ... bioRxiv, 2024.03. 28.587131, 2024 | | 2024 |
| Matching cell lines with cancer type and subtype of origin via mutational, epigenomic, and transcriptomic patterns M Salvadores, F Fuster-Tormo, F Supek EUROPEAN JOURNAL OF HUMAN GENETICS 30 (SUPPL 1), 483-483, 2022 | | 2022 |
